SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15148575
Source:
http://linkedlifedata.com/resource/pubmed/id/15148575
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0007134
,
umls-concept:C0018591
,
umls-concept:C0019721
,
umls-concept:C0030705
,
umls-concept:C0036525
,
umls-concept:C0456387
,
umls-concept:C0681842
,
umls-concept:C1274040
,
umls-concept:C1522484
pubmed:dateCreated
2004-9-14
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/1304110
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm
,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines
,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1433-0563
pubmed:author
pubmed-author:CavettJ WJW
,
pubmed-author:EllerhorstJ AJA
,
pubmed-author:Fernandez-VinaM AMA
,
pubmed-author:FischerHH
,
pubmed-author:GrimmE AEA
,
pubmed-author:HildebrandW HWH
,
pubmed-author:HodgesSS
,
pubmed-author:PoindexterNN
pubmed:issnType
Electronic
pubmed:volume
43 Suppl 3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S137
pubmed:dateRevised
2009-8-20
pubmed:meshHeading
pubmed-meshheading:15148575-Alleles
,
pubmed-meshheading:15148575-Antigens, Neoplasm
,
pubmed-meshheading:15148575-Carcinoma, Renal Cell
,
pubmed-meshheading:15148575-Cytokines
,
pubmed-meshheading:15148575-Disease-Free Survival
,
pubmed-meshheading:15148575-Gene Frequency
,
pubmed-meshheading:15148575-Genotype
,
pubmed-meshheading:15148575-Haplotypes
,
pubmed-meshheading:15148575-Heterozygote Detection
,
pubmed-meshheading:15148575-Histocompatibility Antigens Class II
,
pubmed-meshheading:15148575-Histocompatibility Testing
,
pubmed-meshheading:15148575-Homozygote
,
pubmed-meshheading:15148575-Humans
,
pubmed-meshheading:15148575-Kidney Neoplasms
,
pubmed-meshheading:15148575-Neoplasm Metastasis
,
pubmed-meshheading:15148575-Prognosis
,
pubmed-meshheading:15148575-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC.
pubmed:affiliation
The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030-4095, USA. jaellerh@mail.mdanderson.com
pubmed:publicationType
Journal Article